Prof. Abraham is Professor of Internal Medicine and Chief of the Division of Cardiovascular Medicine at the Ohio State University College of Medicine. Prof. Abraham earned his medical degree from Harvard Medical School, following which he completed his residency in Internal Medicine and fellowships in Cardiovascular Disease and Advance Heart Failure/ Transplant Cardiology at the University of Colorado Health Sciences Centre. Prof Abraham’s research interests include haemodynamic and neurohormonal mechanisms in heart failure, sleep disordered breathing in heart failure, and clinical drug and device trials in heart failure. Prof Abraham has participated as a site Principal Investigator in more than 100 multicenter clinical drug and device trials. Prof. Abraham has also participated in all regulatory phases of new drug and device development from pre-clinical evaluation to Pre-Market Approval and New Drug Application submission and approval. Prof. Abraham has authored more than 700 original papers, abstracts, book chapters and review articles. His work has been published in high impact journals, including the New England Journal of Meicine, The Lancet, the Journal of the American Medical Association, Circulation, the European Heart Journal, and the Journal of the American College of Cardiology. Prof. Abraham has co-authored national heart failure practice guidelines and co-edited a leading textbook on heart failure entitled Heart Failure: A Practical Approach to Treatment. Prof Abraham serves on the editorial boards of several major journals. In 2014 and again in 2015, he was named to the Thomson Reuters Highly cited Researchers list and as one of The World’s Most Inflential Scientific Minds.

Cardiovascular Medicine